Does China's centralized volume-based drug procurement policy facilitate the transition from imitation to innovation for listed pharmaceutical companies? Empirical tests based on double difference model.

Front Pharmacol · 2023 · PMC10266233 · PMID 37324496

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally insignificantno p-value reported

The coefficient of the double interaction term in 2019 after implementation is marginally insignificant.

also in 154 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.